Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study

Standard

Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study. / Dickow, Jannis; Gunawardene, Melanie A; Willems, Stephan; Feldhege, Johannes; Wohlmuth, Peter; Bachmann, Martin; Bergmann, Martin W; Gesierich, Wolfgang; Nowak, Lorenz; Pape, Ulrich-Frank; Schreiber, Ruediger; Wirtz, Sebastian; Twerenbold, Raphael; Sheikhzadeh, Sara; Gessler, Nele.

In: PLOS ONE, Vol. 18, No. 9, 2023, p. e0292017.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Dickow, J, Gunawardene, MA, Willems, S, Feldhege, J, Wohlmuth, P, Bachmann, M, Bergmann, MW, Gesierich, W, Nowak, L, Pape, U-F, Schreiber, R, Wirtz, S, Twerenbold, R, Sheikhzadeh, S & Gessler, N 2023, 'Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study', PLOS ONE, vol. 18, no. 9, pp. e0292017. https://doi.org/10.1371/journal.pone.0292017

APA

Dickow, J., Gunawardene, M. A., Willems, S., Feldhege, J., Wohlmuth, P., Bachmann, M., Bergmann, M. W., Gesierich, W., Nowak, L., Pape, U-F., Schreiber, R., Wirtz, S., Twerenbold, R., Sheikhzadeh, S., & Gessler, N. (2023). Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study. PLOS ONE, 18(9), e0292017. https://doi.org/10.1371/journal.pone.0292017

Vancouver

Bibtex

@article{a40cfe1a5e614ac5a0f7d8224b8a7ae2,
title = "Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study",
abstract = "BACKGROUND: With the emergence of new subvariants, the disease severity of Severe Acute Respiratory Syndrome Coronavirus-2 has attenuated. This study aimed to compare the disease severity in patients hospitalized with omicron variant infection to those with influenza infection.METHODS: We compared data from the multicenter observational, prospective, epidemiological {"}CORONA Germany{"} (Clinical Outcome and Risk in hospitalized COVID-19 patients) study on patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 to retrospective data on influenza infection cases from November 2016 to August 2022. Severe Acute Respiratory Syndrome Coronavirus-2 cases were classified as wild-type/delta variant before January 2022, or omicron variant from January 2022 onward. The primary outcome was in-hospital mortality, adjusted for age, gender, and comorbidities.RESULTS: The study included 35,806 patients from 53 hospitals in Germany, including 4,916 patients (13.7%) with influenza infection, 16,654 patients (46.5%) with wild-type/delta variant infection, and 14,236 patients (39.8%) with omicron variant infection. In-hospital mortality was highest in patients with wild-type/delta variant infection (16.8%), followed by patients with omicron variant infection (8.4%) and patients with influenza infection (4.7%). In the adjusted analysis, higher age was the strongest predictor for in-hospital mortality (age 80 years vs. age 50 years: OR 4.25, 95% CI 3.10-5.83). Both, patients with wild-type/delta variant infection (OR 3.54, 95% CI 3.02-4.15) and patients with omicron variant infection (OR 1.56, 95% CI 1.32-1.84) had a higher risk for in-hospital mortality than patients with influenza infection.CONCLUSION: After adjusting for age, gender and comorbidities, patients with wild-type/delta variant infection had the highest risk for in-hospital mortality compared to patients with influenza infection. Even for patients with omicron variant infection, the adjusted risk for in-hospital mortality was higher than for patients with influenza infection. The adjusted risk for in-hospital mortality showed a strong age dependency across all virus types and variants.TRIAL REGISTRATION NUMBER: NCT04659187.",
author = "Jannis Dickow and Gunawardene, {Melanie A} and Stephan Willems and Johannes Feldhege and Peter Wohlmuth and Martin Bachmann and Bergmann, {Martin W} and Wolfgang Gesierich and Lorenz Nowak and Ulrich-Frank Pape and Ruediger Schreiber and Sebastian Wirtz and Raphael Twerenbold and Sara Sheikhzadeh and Nele Gessler",
note = "Copyright: {\textcopyright} 2023 Dickow et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",
year = "2023",
doi = "10.1371/journal.pone.0292017",
language = "English",
volume = "18",
pages = "e0292017",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

RIS

TY - JOUR

T1 - Higher in-hospital mortality in SARS-CoV-2 omicron variant infection compared to influenza infection-Insights from the CORONA Germany study

AU - Dickow, Jannis

AU - Gunawardene, Melanie A

AU - Willems, Stephan

AU - Feldhege, Johannes

AU - Wohlmuth, Peter

AU - Bachmann, Martin

AU - Bergmann, Martin W

AU - Gesierich, Wolfgang

AU - Nowak, Lorenz

AU - Pape, Ulrich-Frank

AU - Schreiber, Ruediger

AU - Wirtz, Sebastian

AU - Twerenbold, Raphael

AU - Sheikhzadeh, Sara

AU - Gessler, Nele

N1 - Copyright: © 2023 Dickow et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2023

Y1 - 2023

N2 - BACKGROUND: With the emergence of new subvariants, the disease severity of Severe Acute Respiratory Syndrome Coronavirus-2 has attenuated. This study aimed to compare the disease severity in patients hospitalized with omicron variant infection to those with influenza infection.METHODS: We compared data from the multicenter observational, prospective, epidemiological "CORONA Germany" (Clinical Outcome and Risk in hospitalized COVID-19 patients) study on patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 to retrospective data on influenza infection cases from November 2016 to August 2022. Severe Acute Respiratory Syndrome Coronavirus-2 cases were classified as wild-type/delta variant before January 2022, or omicron variant from January 2022 onward. The primary outcome was in-hospital mortality, adjusted for age, gender, and comorbidities.RESULTS: The study included 35,806 patients from 53 hospitals in Germany, including 4,916 patients (13.7%) with influenza infection, 16,654 patients (46.5%) with wild-type/delta variant infection, and 14,236 patients (39.8%) with omicron variant infection. In-hospital mortality was highest in patients with wild-type/delta variant infection (16.8%), followed by patients with omicron variant infection (8.4%) and patients with influenza infection (4.7%). In the adjusted analysis, higher age was the strongest predictor for in-hospital mortality (age 80 years vs. age 50 years: OR 4.25, 95% CI 3.10-5.83). Both, patients with wild-type/delta variant infection (OR 3.54, 95% CI 3.02-4.15) and patients with omicron variant infection (OR 1.56, 95% CI 1.32-1.84) had a higher risk for in-hospital mortality than patients with influenza infection.CONCLUSION: After adjusting for age, gender and comorbidities, patients with wild-type/delta variant infection had the highest risk for in-hospital mortality compared to patients with influenza infection. Even for patients with omicron variant infection, the adjusted risk for in-hospital mortality was higher than for patients with influenza infection. The adjusted risk for in-hospital mortality showed a strong age dependency across all virus types and variants.TRIAL REGISTRATION NUMBER: NCT04659187.

AB - BACKGROUND: With the emergence of new subvariants, the disease severity of Severe Acute Respiratory Syndrome Coronavirus-2 has attenuated. This study aimed to compare the disease severity in patients hospitalized with omicron variant infection to those with influenza infection.METHODS: We compared data from the multicenter observational, prospective, epidemiological "CORONA Germany" (Clinical Outcome and Risk in hospitalized COVID-19 patients) study on patients infected with Severe Acute Respiratory Syndrome Coronavirus-2 to retrospective data on influenza infection cases from November 2016 to August 2022. Severe Acute Respiratory Syndrome Coronavirus-2 cases were classified as wild-type/delta variant before January 2022, or omicron variant from January 2022 onward. The primary outcome was in-hospital mortality, adjusted for age, gender, and comorbidities.RESULTS: The study included 35,806 patients from 53 hospitals in Germany, including 4,916 patients (13.7%) with influenza infection, 16,654 patients (46.5%) with wild-type/delta variant infection, and 14,236 patients (39.8%) with omicron variant infection. In-hospital mortality was highest in patients with wild-type/delta variant infection (16.8%), followed by patients with omicron variant infection (8.4%) and patients with influenza infection (4.7%). In the adjusted analysis, higher age was the strongest predictor for in-hospital mortality (age 80 years vs. age 50 years: OR 4.25, 95% CI 3.10-5.83). Both, patients with wild-type/delta variant infection (OR 3.54, 95% CI 3.02-4.15) and patients with omicron variant infection (OR 1.56, 95% CI 1.32-1.84) had a higher risk for in-hospital mortality than patients with influenza infection.CONCLUSION: After adjusting for age, gender and comorbidities, patients with wild-type/delta variant infection had the highest risk for in-hospital mortality compared to patients with influenza infection. Even for patients with omicron variant infection, the adjusted risk for in-hospital mortality was higher than for patients with influenza infection. The adjusted risk for in-hospital mortality showed a strong age dependency across all virus types and variants.TRIAL REGISTRATION NUMBER: NCT04659187.

U2 - 10.1371/journal.pone.0292017

DO - 10.1371/journal.pone.0292017

M3 - SCORING: Journal article

C2 - 37756299

VL - 18

SP - e0292017

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 9

ER -